Salut Brunet

11.5k total citations
201 papers, 6.7k citations indexed

About

Salut Brunet is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Salut Brunet has authored 201 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Hematology, 52 papers in Oncology and 48 papers in Genetics. Recurrent topics in Salut Brunet's work include Acute Myeloid Leukemia Research (75 papers), Hematopoietic Stem Cell Transplantation (72 papers) and Acute Lymphoblastic Leukemia research (41 papers). Salut Brunet is often cited by papers focused on Acute Myeloid Leukemia Research (75 papers), Hematopoietic Stem Cell Transplantation (72 papers) and Acute Lymphoblastic Leukemia research (41 papers). Salut Brunet collaborates with scholars based in Spain, Netherlands and Belgium. Salut Brunet's co-authors include Jorge Sierra, Rodrigo Martino, Anna Sureda, Josep‐María Ribera, Josep Nomdedéu, Jordi Esteve, Javier Briones, Mar Tormo, Albert Altés and Miguel Á. Sanz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Salut Brunet

198 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salut Brunet Spain 45 4.2k 1.8k 1.6k 1.4k 1.1k 201 6.7k
Renato Fanin Italy 42 3.6k 0.9× 1.4k 0.8× 2.0k 1.3× 705 0.5× 1.4k 1.3× 226 6.6k
Benedetto Bruno Italy 51 5.5k 1.3× 1.6k 0.9× 2.6k 1.7× 1.0k 0.8× 1.3k 1.1× 278 8.0k
Agnès Buzyn France 44 3.0k 0.7× 822 0.5× 1.5k 1.0× 1.9k 1.4× 951 0.8× 137 5.7k
Ibrahim Yakoub‐Agha France 47 4.7k 1.1× 1.4k 0.8× 2.8k 1.8× 1.3k 0.9× 1.1k 1.0× 407 7.6k
Daniel R. Couriel United States 45 4.7k 1.1× 795 0.5× 1.8k 1.1× 1.1k 0.8× 895 0.8× 155 6.6k
E. Thiel Germany 46 2.1k 0.5× 1.4k 0.8× 1.7k 1.1× 1.7k 1.2× 1.4k 1.2× 208 6.9k
R Powles United Kingdom 41 4.1k 1.0× 1.4k 0.8× 2.2k 1.4× 949 0.7× 779 0.7× 194 6.2k
Chitra Hosing United States 51 5.1k 1.2× 1.3k 0.7× 3.2k 2.1× 1.2k 0.8× 1.5k 1.3× 372 8.9k
Giovanna Meloni Italy 40 3.7k 0.9× 1.3k 0.7× 1.3k 0.9× 1.9k 1.4× 1.0k 0.9× 159 5.6k
Álvaro Urbano-Ispizúa Spain 44 3.3k 0.8× 819 0.5× 1.7k 1.1× 748 0.5× 1.3k 1.1× 215 6.1k

Countries citing papers authored by Salut Brunet

Since Specialization
Citations

This map shows the geographic impact of Salut Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salut Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salut Brunet more than expected).

Fields of papers citing papers by Salut Brunet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salut Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salut Brunet. The network helps show where Salut Brunet may publish in the future.

Co-authorship network of co-authors of Salut Brunet

This figure shows the co-authorship network connecting the top 25 collaborators of Salut Brunet. A scholar is included among the top collaborators of Salut Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salut Brunet. Salut Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garrido, Ana, Elena Bussaglia, Marta Pratcorona, et al.. (2019). Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients. European Journal Of Haematology. 103(3). 208–214. 6 indexed citations
2.
Cuéllar‐García, Carolina, Salut Brunet, Javier Briones, et al.. (2018). Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy. Clinical Lymphoma Myeloma & Leukemia. 18(11). 737–742. 2 indexed citations
3.
Torrebadell, Montserrat, Marina Díaz‐Beyá, Susana G. Kalko, et al.. (2018). A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia & lymphoma. 59(10). 2394–2404. 16 indexed citations
4.
Gallardo, David, Rocío Rodriguez, Ismael Buño, et al.. (2017). Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches. Biology of Blood and Marrow Transplantation. 23(12). 2042–2047. 4 indexed citations
5.
Barata, Anna, Rodrigo Martino, Ignasi Gich, et al.. (2017). Do Patients and Physicians Agree When They Assess Quality of Life?. Biology of Blood and Marrow Transplantation. 23(6). 1005–1010. 6 indexed citations
6.
Díaz‐Beyá, Marina, Salut Brunet, Josep Nomdedéu, et al.. (2013). MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia. 28(4). 804–812. 47 indexed citations
7.
Valcárcel, David, Pau Montesinos, Isabel Sánchez‐Ortega, et al.. (2011). A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemia. Cancer. 118(2). 410–417. 22 indexed citations
8.
Delgado, Julio, Srinivas Pillai, Salut Brunet, et al.. (2009). Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case–control retrospective analysis. Annals of Oncology. 20(12). 2007–2012. 15 indexed citations
9.
Lasa, Adriana, Camino Estivill, Elena Bussaglia, et al.. (2009). WT1 monitoring in core binding factor AML: Comparison with specific chimeric products. Leukemia Research. 33(12). 1643–1649. 17 indexed citations
10.
Delgado, Julio, E. Moreno, José Luís Piñana, et al.. (2009). Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen. Cytotherapy. 11(3). 356–361. 3 indexed citations
11.
Sierra, Jorge, Rodrigo Martino, B. Sánchez, et al.. (2008). Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia. Bone Marrow Transplantation. 41(5). 425–437. 11 indexed citations
12.
Brunet, Salut, Juan José Berlanga, Mar Tormo, et al.. (2008). CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia. 23(3). 486–491. 46 indexed citations
13.
Serrano, Elena, Maria J. Carnicer, Camino Estivill, et al.. (2008). Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype. Leukemia & lymphoma. 49(6). 1178–1183. 20 indexed citations
14.
Subirá, Maricel, Anna Sureda, Rodrigo Martino, et al.. (2003). Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. Bone Marrow Transplantation. 32(9). 869–872. 17 indexed citations
15.
Perea, G, Anna Sureda, Rodrigo Martino, et al.. (2001). Predictive factors for a successful mobilization of peripheral blood CD34 + cells in multiple myeloma. Annals of Hematology. 80(10). 592–597. 65 indexed citations
16.
Nomdedéu, Josep, Montserrat Baiget, Gianluca Gaïdano, et al.. (1998). p53 Mutation in a Case of Blastic Transformation of Follicular Lymphoma with Double bcl-2 Rearrangement (MBR and VCR). Leukemia & lymphoma. 29(5-6). 595–605. 13 indexed citations
17.
Solano, Carlos, Carmen Martı́nez, Salut Brunet, et al.. (1998). Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Bone Marrow Transplantation. 22(12). 1129–1135. 57 indexed citations
18.
Martino, Rodrigo, et al.. (1993). Treatment of Refractory and Relapsed Adult Acute Leukemia Using a Uniform Chemotherapy Protocol. Leukemia & lymphoma. 11(5-6). 393–398. 7 indexed citations
19.
Ljungman, Per, Dan Engelhard, Hartmut Link, et al.. (1992). Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group. Clinical Infectious Diseases. 14(4). 831–835. 139 indexed citations
20.
Aventı́n, Anna, et al.. (1990). Translocation (3;21) in a patient with secondary hematological malignancy. Cancer Genetics and Cytogenetics. 50(2). 227–229. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026